Bitech Technologies (BTTC) 10-Q 12 May 16 2016 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2016	May. 12, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Spine Injury Solutions, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		20,105,882
Amendment Flag	false
Entity Central Index Key	1,066,764
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash	$ 127,052	$ 173,647
Accounts receivable, net	1,601,413	1,301,124
Prepaid expenses	157,000	159,250
Inventories	78,376	75,460
Total current assets	1,963,841	1,709,481
Accounts receivable, net of allowance for doubtful accountsof $548,690 and $503,477 at March 31, 2016 and December 31, 2015, respectively	3,187,940	3,399,896
Property and equipment, net	74,118	78,937
Intangible assets and goodwill, net	170,200	170,200
Total assets	5,396,099	5,358,514
Current liabilities:
Accounts payable and accrued liabilities	67,447	100,457
Due to related parties	57,336	29,400
Current portion of long-term debt, net	550,000	500,000
Total current liabilities	674,783	629,857
Line of credit	1,125,000	1,145,000
Notes payable and long-term debt, net of discount	0	50,000
Total liabilities	$ 1,799,783	$ 1,824,857
Commitments and contingencies
Stockholders' equity:
Common stock: $0.001 par value, 50,000,000 shares authorized, 19,905,882 and 19,780,882 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	$ 19,906	$ 19,781
Additional paid-in capital	19,917,945	19,908,571
Accumulated deficit	(16,341,535)	(16,394,695)
Total stockholders' equity	3,596,316	3,533,657
Total liabilities and stockholders’ equity	$ 5,396,099	$ 5,358,514

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Allowance for doubtful accounts (in Dollars)	$ 548,690	$ 503,477
Common stock: par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock: shares authorized	50,000,000	50,000,000
Common stock: shares issued	19,905,882	19,780,882
Common stock: shares outstanding	19,905,882	19,780,882

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net revenue	$ 667,264	$ 416,298
Cost of providing services, including amounts billed by a related party of $170,238 and $125,778 during the three months ended March 31, 2016 and 2015, respectively	228,310	180,966
Gross profit	438,954	235,332
Operating, general and administrative expenses	366,513	482,013
Research and development	6,149	82,468
Income (loss) from operations	66,292	(329,149)
Other income and (expense):
Other income	2,297	4,596
Interest expense	(15,430)	(21,313)
Total other income and (expense)	(13,133)	(16,717)
Net income (loss)	$ 53,159	$ (345,866)
Basic and diluted earnings (loss) per common share (in Dollars per share)	$ 0	$ (0.02)
Shares used in earnings (loss) per common share:
Basic (in Shares)	19,843,382	19,465,882
Diluted (in Shares)	19,843,382	19,465,882

UNAUDITED CONDENSED CONSOLIDAT5

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cost of providing services, related party	$ 170,238	$ 125,778

UNAUDITED CONDENSED CONSOLIDAT6

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net income (loss)	$ 53,159	$ (345,866)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	66,200	75,000
Stock based compensation	39,500	50,833
Depreciation and amortization expense	4,819	7,389
Changes in operating assets and liabilities:
Accounts receivable, net	(154,533)	(19,824)
Inventories	(2,916)	(12,900)
Prepaid expenses and other assets	(27,750)	(13,454)
Due to related party	27,936	36,215
Accounts payable and accrued liabilities	(33,010)	(8,150)
Net cash used in operating activities	(26,595)	(230,757)
Cash flows from investing activities:
Purchase of equipment	0	(10,847)
Net cash used in investing activities	0	(10,847)
Cash flows from financing activities:
Payment of notes payable and long-term debt	0	(300,000)
Net proceeds from line of credit	(20,000)	525,000
Net cash (used in) provided by financing activities	(20,000)	225,000
Net decrease in cash and cash equivalents	(46,595)	(16,604)
Cash and cash equivalents at beginning of period	173,647	358,052
Cash and cash equivalents at end of period	127,052	341,448
Supplementary disclosure of cash flow information:
Interest paid	15,430	21,213
Taxes paid	$ 0	$ 0

NOTE 1. DESCRIPTION OF BUSINESS

NOTE 1. DESCRIPTION OF BUSINESS	3 Months Ended
	Mar. 31, 2016
Disclosure Text Block [Abstract]
Nature of Operations [Text Block]	NOTE 1. DESCRIPTION OF BUSINESS Spine Injury Solutions Inc. (the “Company”, “we” or “us”) was incorporated under the laws of Delaware on March 4, 1998. We changed our name to Spine Injury Solutions Inc. on September 1, 2015. We are a technology, marketing, management, billing, and collection company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons and other healthcare providers for necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our goal is to become a leader in providing management services to spine and orthopedic surgeons and other healthcare providers to facilitate proper treatment of their injured clients. By pre-funding the providers accounts receivable, which includes diagnostic testing and non-invasive and surgical care, patients are not unnecessarily delayed or prevented from obtaining needed treatment. By facilitating early treatment through affiliated doctors, we believe that health conditions can be prevented from escalating and injured victims can be quickly placed on the road to recovery. Through our affiliate system, we facilitate spine surgeons, orthopedic surgeons and other healthcare providers to provide reasonable, necessary, and appropriate treatments to patients with musculo-skeletal spine injuries. We assist the centers that provide the spine diagnostic injections and treatment and pay the doctors a fee for the medical procedures they performed. After a patient is billed for the procedures performed by the affiliated doctor, we take control of the patients’ unpaid bill and oversee collection. In most instances, the patient is a plaintiff in an accident case, where the patient is represented by an attorney. Typically, the defendant (and/or the insurance company of the defendant) in the accident case pays the patient’s bill upon settlement or final judgment of the accident case. The payment to us is made through the attorney of the patient. In most cases, we must agree to the settlement price and the patient must sign off on the settlement. Once we are paid, the patient’s attorney can receive payment for his or her legal fee. We currently are affiliated with four spine injury diagnostic centers in the United States, which are located in Houston, Texas; Odessa, Texas; Tyler, Texas and San Antonio, Texas. We are seeking additional funding for expansion by way of reasonable debt financing to accelerate this future development. In connection with this strategy, we plan to open additional diagnostic centers in new market areas that are attractive under our business model, assuming adequate funds are available. We own a device and process by which a video recording system is attached to a fluoroscopic x-ray machine, the “four camera technology,” that we believe can attract additional physicians and patients, expedite settlements and provide us with additional revenue streams. We have refined the technology, through research and development resulting in a fully commercialized Quad Video Halo System 3.0. Using this technology, diagnostic procedures are recorded from four separate video feeds that capture views from both inside and outside the body, and a video is made which is given to the patient’s representative to verify the treatment received. We believe the video will expedite the settlement process. Additionally, with regulatory approval (if necessary) we anticipate independent medical representatives will sell Quad Video Halo units to outside hospitals and clinics. In September 2014, we created a wholly owned subsidiary Quad Video Halo, Inc. The purpose of this entity is to hold certain company assets affiliated with the Quad Video Halo units.

NOTE 2. GOING CONCERN CONSIDERA

NOTE 2. GOING CONCERN CONSIDERATIONS	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	NOTE 2. GOING CONCERN CONSIDERATIONS Since our inception in 1998, until commencement of our spine injury diagnostic operations in August, 2009, our expenses substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit from operations of $15,004,698 as of December 31, 2009. Since that time, our accumulated deficit has increased $1,336,837 to $16,341,535 as of March 31, 2016. We plan to increase our operating expenses as we increase our service development, marketing efforts and brand building activities. We also plan to increase our general and administrative functions to support our growing operations. We will need to generate significant revenues to achieve our business plan. Our continued existence is dependent upon our ability to successfully execute our business plan, as well as our ability to increase revenue from services and obtain additional capital from borrowing and selling securities, as needed, to fund our operations. There is no assurance that additional capital can be obtained or that it can be obtained on terms that are favorable to us and our existing stockholders. Any expectation of future profitability is dependent upon our ability to expand and develop our healthcare services business, of which there can be no assurances.

NOTE 3. CRITICAL ACCOUNTING POL

NOTE 3. CRITICAL ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 3. CRITICAL ACCOUNTING POLICIES The following are summarized accounting policies considered to be critical by our management: Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC”). Certain information and footnote disclosures, normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. Nevertheless, we believe that the disclosures are adequate to make the information presented not misleading. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our 2015 Annual Report as filed on Form 10-K. In the opinion of management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position with respect to the interim condensed consolidated financial statements and the results of its operations for the interim period ended March 31, 2016, have been included. The results of operations for interim periods are not necessarily indicative of the results for a full year. Basis of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Spine Injury Solutions, Inc. and its wholly owned subsidiary, Quad Video Halo, Inc. All material intercompany balances of transactions have been eliminated upon consolidation. Accounting Method Our financial statements are prepared using the accrual basis of accounting in accordance with U.S. GAAP. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of our condensed consolidated financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of our financial position and results of operations. Revenue Recognition Revenues are recognized in accordance with SEC staff accounting bulletin, Topic 13, Revenue Recognition, which specifies that only when persuasive evidence for an arrangement exists; the fee is fixed or determinable; and collection is reasonably assured can revenue be recognized. Persuasive evidence of an arrangement is obtained prior to services being rendered when the patient completes and signs the medical and financial paperwork. Delivery of services is considered to have occurred when medical diagnostic services are provided to the patient. The price and terms for the services are considered fixed and determinable at the time that the medical services are provided and are based upon the type and extent of the services rendered. Our credit policy has been established based upon extensive experience by management in the industry and has been determined to ensure that collectability is reasonably assured. Payment for services are primarily made to us by a third party and the credit policy includes terms of net 240 days for collections; however, collections occur upon settlement or judgment of cases (see Note 4). Fair Value of Financial Instruments Cash, accounts receivable, accounts payable and accrued liabilities, and notes payable as reflected in the condensed consolidated financial statements, approximates fair value. Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect these estimates. Cash and Cash Equivalents Cash and cash equivalents consist of liquid investments with original maturities of three months or less. Cash equivalents are stated at cost, which approximates fair value. We maintain cash and cash equivalents in banks which at times may exceed federally insured limits. We have not experienced any losses on these deposits. Intangible Assets and Goodwill Intangible assets acquired are initially recognized at cost. Intangible assets acquired in a business combination are recognized at their estimated fair value at the date of acquisition. Intangibles with a finite life are amortized, ratably, based on the contractual terms of the associated agreements. Goodwill recognized in a business combination is subjective and represents the value of the excess amount given to the acquired company above the estimated fair market value of the identifiable net assets on the acquisition date. The goodwill amount is tested for impairment when events or circumstances indicate the asset might be impaired, but at least annually. Impairment occurs when the original amount of goodwill exceeds the value of the expected future net cash flows from the business acquired. As of March 31, 2016 and December 31, 2015, no impairment to the asset was determined to have occurred. Long-Lived Assets We periodically review and evaluate long-lived assets such as intangible assets, when events and circumstances indicate that the carrying amount of these assets may not be recoverable. In performing our review for recoverability, we estimate the future cash flows expected to result from the use of such assets and its eventual disposition. If the sum of the expected undiscounted future operating cash flows is less than the carrying amount of the related assets, an impairment loss is recognized in the consolidated statements of operations. Measurement of the impairment loss is based on the excess of the carrying amount of such assets over the fair value calculated using discounted expected future cash flows. At March 31, 2016 and December 31, 2015, no impairment of the long-lived assets was determined to have occurred. Concentrations of Credit Risk Assets that expose us to credit risk consist primarily of cash and accounts receivable. Our accounts receivable are from a diversified customer base and, therefore, we believe the concentration of credit risk is minimal. We evaluate the creditworthiness of customers before any services are provided. We record a discount based on the nature of our business, collection trends, and an assessment of our ability to fully realize amounts billed for services. Additionally, we have established an allowance for doubtful accounts in the amount of $548,690 and $503,477, at March 31, 2016 and December 31, 2015, respectively. Stock Based Compensation We account for the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors, including employee stock options, based on estimated fair values. Under authoritative guidance issued by the Financial Accounting Standards Board (“FASB”), companies are required to estimate the fair value or calculated value of share-based payment awards on the date of grant using an option-pricing model. The value of awards that are ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated statements of operations. We use the Black-Scholes Option Pricing Model to determine the fair-value of stock-based awards. During the quarters ended March 31, 2016 and 2015, we recognized compensation expense related to our stock options of $0 and $72,000, respectively. We also recognized compensation expense for issuances of our common stock in exchange for services of $39,500 and $50,833 during the quarters ended March 31, 2016 and 2015, respectively. Income Taxes We account for income taxes in accordance with the liability method. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax basis. We establish a valuation allowance to the extent that it is more likely than not that deferred tax assets will not be utilized against future taxable income. Uncertain Tax Positions Accounting Standards Codification “ASC” Topic 740-10-25 defines the minimum threshold a tax position is required to meet before being recognized in the financial statements as “more likely than not” (i.e., a likelihood of occurrence greater than fifty percent). Under ASC Topic 740-10-25, the recognition threshold is met when an entity concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination by the relevant taxing authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard, or are resolved through negotiation or litigation with the taxing authority, or upon expiration of the statute of limitations. De-recognition of a tax position that was previously recognized occurs when an entity subsequently determines that a tax position no longer meets the more likely than not threshold of being sustained. We are subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, we may incur additional tax expense based upon the outcomes of such matters. In addition, when applicable, we will adjust tax expense to reflect our ongoing assessments of such matters which require judgment and can materially increase or decrease our effective rate as well as impact operating results. Under ASC Topic 740-10-25, only the portion of the liability that is expected to be paid within one year is classified as a current liability. As a result, liabilities expected to be resolved without the payment of cash (e.g. resolution due to the expiration of the statute of limitations) or are not expected to be paid within one year are not classified as current. We have recently adopted a policy of recording estimated interest and penalties as income tax expense and tax credits as a reduction in income tax expense. For the three months ended March 31, 2016 and 2015, we recognized no estimated interest or penalties as income tax expense. With few exceptions, the Company is no longer subject to federal or state income tax examinations for years before 2012. Legal Costs and Contingencies In the normal course of business, we incur costs to hire and retain external legal counsel to advise us on regulatory, litigation and other matters. We expense these costs as the related services are received. If a loss is considered probable and the amount can be reasonably estimated, we recognize an expense for the estimated loss. If we have the potential to recover a portion of the estimated loss from a third party, we make a separate assessment of recoverability and reduce the estimated loss if recovery is also deemed probable. Earnings (Loss) per Share Basic and diluted earnings (loss) per common share is presented in accordance with ASC Topic 260, “Earnings per Share,” for all periods presented. During the three months ended March 31, 2016 and 2015, common stock equivalents from outstanding stock options, warrants and convertible debt have been excluded from the calculation of the diluted earnings (loss) per share in the statements of operations, because all such securities were anti-dilutive. The earnings (loss) per share is calculated by dividing the net income (loss) by the weighted average number of shares outstanding during the periods. Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606). In June 2014, the FASB issued ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved after the Requisite Service Period. In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern. In January 2015, the FASB issued ASU No. 2015-01, Income Statement – Extraordinary and Unusual Items (Subtopic 225-20): Simplified Income Statement Presentation by Eliminating the Concept of Extraordinary Items. Income statement – Extraordinary and Unusual Items, In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, TM In April 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. In February 2016, the FASB issued ASU No. 2016-02, Leases

NOTE 4. ACCOUNTS RECEIVABLE

NOTE 4. ACCOUNTS RECEIVABLE	3 Months Ended
	Mar. 31, 2016
Receivables [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	NOTE 4. ACCOUNTS RECEIVABLE We recognize revenue and accounts receivable in accordance with SEC staff accounting bulletin, Topic 13, “Revenue Recognition,” which requires persuasive evidence that a sales arrangement exists; the fee is fixed or determinable; and collection is reasonably assured before revenue is recognized. We manage certain spine injury diagnostic centers where independent healthcare providers perform medical services for patients. We pay the healthcare providers a fixed rate for medical services performed. The patients are billed based on Current Procedural Terminology (“CPT”) codes for the medical procedure performed. CPT codes are numbers assigned to every task and service a medical practitioner may provide to a patient including medical, surgical and diagnostic services. CPT codes are developed, maintained and copyrighted by the American Medical Association. Patients are billed at the normal billing amount, based on national averages, for a particular CPT code procedure. We take control of the patients’ unpaid bills. Revenue and corresponding accounts receivable are recognized by reference to “net revenue” and “accounts receivable, net” which is defined as gross amounts billed using CPT codes less account discounts that are expected to result when individual cases are ultimately settled. A discount rate of 48% and 52%, respectively, based on settled patient cases, was used to reduce revenue to 52% and 48%, respectively, of CPT code billings (“gross revenue”) during the three months ended March 31, 2016 and 2015. The patients who receive medical services at the diagnostic centers are typically plaintiffs in accident lawsuits. The timing of collection of receivables is dependent on the timing of a settlement or judgment of each individual case associated with these patients. Historical experience, through 2015, demonstrated that the collection period for individual cases may extend for two years or more. Accordingly, we have classified receivables as current or long term based on our experience, which indicates that as of March 31, 2016 and December 31, 2015 that 30% and 25%, respectively, of cases will be subject to a settlement or judgment within one year of a medical procedure. We take the following steps to establish an arrangement between all parties and facilitate collection upon settlement or final judgment of cases: · The patient completed and signed medical and financial paperwork, which included an acknowledgement of the patient’s responsibility of payment for the services provided. Additionally, the paperwork should include an assignment of benefits derived from any settlement or judgment of the patient’s case. · The patient’s attorney issued the healthcare provider a Letter of Protection designed to guarantee payment for the medical services provided to the patient from proceeds of any settlement or judgment in the accident case. This Letter of Protection also should preclude any case settlement without providing for payment of the patient’s medical bill. · Most of the patients who received medical services at the diagnostic centers have typically been previously referred to a doctor from a plaintiff’s attorney, who performed the initial two to four months of conservative treatment. The doctor then typically refers the patient to one of our healthcare providers for an evaluation because of continuing symptoms. Patients are only accepted if the initial referral was from a reputable plaintiff’s attorney with adequate experience in personal injury lawsuits. Before referring a patient, the attorney is expected to have evaluated the patient’s accident case, including the conditions that gave rise to the patient’s injuries and the extent and quality of general liability insurance held by the defendant. The attorney is also responsible for determining that a settlement favorable to the patient/plaintiff is expected.

NOTE 5. DUE TO RELATED PARTIES

NOTE 5. DUE TO RELATED PARTIES	3 Months Ended
	Mar. 31, 2016
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 5. DUE TO RELATED PARTIES We have an agreement with NSO, which is 100% owned by our Chief Executive Officer, William Donovan, M.D., to provide medical services as our independent contractor at the Houston and Odessa spine injury diagnostic centers. For the quarters ended March 31, 2016 and 2015, we expensed $170,238 and $125,778 related to services provided by NSO. As of March 31, 2016 and December 31, 2015, we had balances payable to NSO of $57,336 and $29,400, respectively. This outstanding payable is non-interest bearing, due on demand and does not follow any specific repayment schedule. We do not directly pay Dr. Donovan (in his individual capacity as a physician) any fees in connection with NSO. However, Dr. Donovan is the sole owner of NSO, and we pay NSO under the terms of our agreement.

NOTE 6. STOCKHOLDERS' EQUITY

NOTE 6. STOCKHOLDERS' EQUITY	3 Months Ended
	Mar. 31, 2016
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 6. STOCKHOLDERS’ EQUITY During the three months ended March 31, 2016, 100,000 shares of common stock vested to Peter Dalrymple, a director of the Company, pursuant to a Financing Agreement whereby he assisted in helping us obtain a revolving line of credit. The shares were valued at $0.30 per share resulting in recognition of expense of $30,000 for the three months ended March 31, 2016. In February, 2016, we issued 25,000 shares of common stock to a consultant, valued at $0.38 per share, totaling $9,500, which was recognized as compensation expense during the three months ended March 31, 2016.

NOTE 7. NOTES PAYABLE

NOTE 7. NOTES PAYABLE	3 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 7. NOTES PAYABLE On June 27, 2012, we issued a $500,000 convertible promissory note bearing interest at 12% per year with an initial maturity date of March 27, 2014, which was extended to March 27, 2015. In December 2014, we made a principal payment of $200,000 on this note and in March 2015 we paid the remaining $300,000. For the quarters ended March 31, 2016 and 2015, we recorded $0 and $8,600 in interest expense related to this note. On August 29, 2012, we issued Peter Dalrymple, a director of the Company, a $1,000,000 three-year secured promissory note bearing interest at 12% per year. This promissory note is secured by $3,000,000 in gross accounts receivable. On the maturity date, one balloon payment of the entire outstanding principal amount plus any accrued and unpaid interest is due. On August 20, 2014, in connection with a Financing Agreement with Mr. Dalrymple, the promissory note was amended to extend the term by one year to mature on August 29, 2016 and the interest rate was reduced to 6%. Additionally, $500,000 of advances under the line of credit with Wells Fargo (as described below) was used as payment of principal and interest on the promissory note. As of March 31, 2016, the note has a principal balance of $500,000. In June 2013, we extended the maturity date of a $50,000 third party note originally due March 9, 2015 to a maturity date of March 9, 2017 in exchange for warrants to purchase 50,000 shares at $0.45 per share. Line of Credit On September 3, 2014, we entered into a $2,000,000 revolving line of credit agreement with Wells Fargo Bank, N.A. Outstanding principal on the line of credit bears interest at the 30 day London Interbank Offered Rate (“LIBOR”) plus 2%, resulting in an effective rate of 2.43% at March 31, 2016. The line of credit matures on August 31, 2017 and is personally guaranteed by Peter Dalrymple, a director of the Company. As of March 31, 2016 and December 31, 2015, outstanding borrowings under the line of credit totaled $1,125,000 and $1,145,000, respectively.

NOTE 8. INCOME TAXES

NOTE 8. INCOME TAXES	3 Months Ended
	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 8. INCOME TAXES We have not made a provision for (benefit from) income taxes for the three months ended March 31, 2016 or 2015, which reflects our valuation allowance established against our benefits from net operating loss carryforwards.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Basis of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Spine Injury Solutions, Inc. and its wholly owned subsidiary, Quad Video Halo, Inc. All material intercompany balances of transactions have been eliminated upon consolidation.
Basis of Accounting, Policy [Policy Text Block]	Accounting Method Our financial statements are prepared using the accrual basis of accounting in accordance with U.S. GAAP.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of our condensed consolidated financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of our financial position and results of operations.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Revenues are recognized in accordance with SEC staff accounting bulletin, Topic 13, Revenue Recognition, which specifies that only when persuasive evidence for an arrangement exists; the fee is fixed or determinable; and collection is reasonably assured can revenue be recognized. Persuasive evidence of an arrangement is obtained prior to services being rendered when the patient completes and signs the medical and financial paperwork. Delivery of services is considered to have occurred when medical diagnostic services are provided to the patient. The price and terms for the services are considered fixed and determinable at the time that the medical services are provided and are based upon the type and extent of the services rendered. Our credit policy has been established based upon extensive experience by management in the industry and has been determined to ensure that collectability is reasonably assured. Payment for services are primarily made to us by a third party and the credit policy includes terms of net 240 days for collections; however, collections occur upon settlement or judgment of cases (see Note 4).
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments Cash, accounts receivable, accounts payable and accrued liabilities, and notes payable as reflected in the condensed consolidated financial statements, approximates fair value. Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect these estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents Cash and cash equivalents consist of liquid investments with original maturities of three months or less. Cash equivalents are stated at cost, which approximates fair value. We maintain cash and cash equivalents in banks which at times may exceed federally insured limits. We have not experienced any losses on these deposits.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Intangible Assets and Goodwill Intangible assets acquired are initially recognized at cost. Intangible assets acquired in a business combination are recognized at their estimated fair value at the date of acquisition. Intangibles with a finite life are amortized, ratably, based on the contractual terms of the associated agreements. Goodwill recognized in a business combination is subjective and represents the value of the excess amount given to the acquired company above the estimated fair market value of the identifiable net assets on the acquisition date. The goodwill amount is tested for impairment when events or circumstances indicate the asset might be impaired, but at least annually. Impairment occurs when the original amount of goodwill exceeds the value of the expected future net cash flows from the business acquired. As of March 31, 2016 and December 31, 2015, no impairment to the asset was determined to have occurred.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long-Lived Assets We periodically review and evaluate long-lived assets such as intangible assets, when events and circumstances indicate that the carrying amount of these assets may not be recoverable. In performing our review for recoverability, we estimate the future cash flows expected to result from the use of such assets and its eventual disposition. If the sum of the expected undiscounted future operating cash flows is less than the carrying amount of the related assets, an impairment loss is recognized in the consolidated statements of operations. Measurement of the impairment loss is based on the excess of the carrying amount of such assets over the fair value calculated using discounted expected future cash flows. At March 31, 2016 and December 31, 2015, no impairment of the long-lived assets was determined to have occurred.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk Assets that expose us to credit risk consist primarily of cash and accounts receivable. Our accounts receivable are from a diversified customer base and, therefore, we believe the concentration of credit risk is minimal. We evaluate the creditworthiness of customers before any services are provided. We record a discount based on the nature of our business, collection trends, and an assessment of our ability to fully realize amounts billed for services. Additionally, we have established an allowance for doubtful accounts in the amount of $548,690 and $503,477, at March 31, 2016 and December 31, 2015, respectively.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock Based Compensation We account for the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors, including employee stock options, based on estimated fair values. Under authoritative guidance issued by the Financial Accounting Standards Board (“FASB”), companies are required to estimate the fair value or calculated value of share-based payment awards on the date of grant using an option-pricing model. The value of awards that are ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated statements of operations. We use the Black-Scholes Option Pricing Model to determine the fair-value of stock-based awards. During the quarters ended March 31, 2016 and 2015, we recognized compensation expense related to our stock options of $0 and $72,000, respectively. We also recognized compensation expense for issuances of our common stock in exchange for services of $39,500 and $50,833 during the quarters ended March 31, 2016 and 2015, respectively.
Income Tax, Policy [Policy Text Block]	Income Taxes We account for income taxes in accordance with the liability method. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax basis. We establish a valuation allowance to the extent that it is more likely than not that deferred tax assets will not be utilized against future taxable income.
Income Tax Uncertainties, Policy [Policy Text Block]	Uncertain Tax Positions Accounting Standards Codification “ASC” Topic 740-10-25 defines the minimum threshold a tax position is required to meet before being recognized in the financial statements as “more likely than not” (i.e., a likelihood of occurrence greater than fifty percent). Under ASC Topic 740-10-25, the recognition threshold is met when an entity concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination by the relevant taxing authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard, or are resolved through negotiation or litigation with the taxing authority, or upon expiration of the statute of limitations. De-recognition of a tax position that was previously recognized occurs when an entity subsequently determines that a tax position no longer meets the more likely than not threshold of being sustained. We are subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, we may incur additional tax expense based upon the outcomes of such matters. In addition, when applicable, we will adjust tax expense to reflect our ongoing assessments of such matters which require judgment and can materially increase or decrease our effective rate as well as impact operating results. Under ASC Topic 740-10-25, only the portion of the liability that is expected to be paid within one year is classified as a current liability. As a result, liabilities expected to be resolved without the payment of cash (e.g. resolution due to the expiration of the statute of limitations) or are not expected to be paid within one year are not classified as current. We have recently adopted a policy of recording estimated interest and penalties as income tax expense and tax credits as a reduction in income tax expense. For the three months ended March 31, 2016 and 2015, we recognized no estimated interest or penalties as income tax expense. With few exceptions, the Company is no longer subject to federal or state income tax examinations for years before 2012.
Legal Costs, Policy [Policy Text Block]	Legal Costs and Contingencies In the normal course of business, we incur costs to hire and retain external legal counsel to advise us on regulatory, litigation and other matters. We expense these costs as the related services are received. If a loss is considered probable and the amount can be reasonably estimated, we recognize an expense for the estimated loss. If we have the potential to recover a portion of the estimated loss from a third party, we make a separate assessment of recoverability and reduce the estimated loss if recovery is also deemed probable.
Earnings Per Share, Policy [Policy Text Block]	Earnings (Loss) per Share Basic and diluted earnings (loss) per common share is presented in accordance with ASC Topic 260, “Earnings per Share,” for all periods presented. During the three months ended March 31, 2016 and 2015, common stock equivalents from outstanding stock options, warrants and convertible debt have been excluded from the calculation of the diluted earnings (loss) per share in the statements of operations, because all such securities were anti-dilutive. The earnings (loss) per share is calculated by dividing the net income (loss) by the weighted average number of shares outstanding during the periods.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606). In June 2014, the FASB issued ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved after the Requisite Service Period. In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern. In January 2015, the FASB issued ASU No. 2015-01, Income Statement – Extraordinary and Unusual Items (Subtopic 225-20): Simplified Income Statement Presentation by Eliminating the Concept of Extraordinary Items. Income statement – Extraordinary and Unusual Items, In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, TM In April 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. In February 2016, the FASB issued ASU No. 2016-02, Leases

NOTE 2. GOING CONCERN CONSIDE16

NOTE 2. GOING CONCERN CONSIDERATIONS (Details) - USD ($)	75 Months Ended
	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2009
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained Earnings (Accumulated Deficit)	$ (16,341,535)	$ (16,394,695)	$ (15,004,698)
Cumulative Effect on Retained Earnings, Net of Tax	$ (1,336,837)

NOTE 3. CRITICAL ACCOUNTING P17

NOTE 3. CRITICAL ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
NOTE 3. CRITICAL ACCOUNTING POLICIES (Details) [Line Items]
Accounts Receivable, Collection Period	240 days
Goodwill, Impairment Loss	$ 0		$ 0
Allowance for Doubtful Accounts Receivable	548,690		$ 503,477
Share-based Compensation	39,500	$ 50,833
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	0	0
Employee Stock Option [Member]
NOTE 3. CRITICAL ACCOUNTING POLICIES (Details) [Line Items]
Share-based Compensation	0	72,000
Common Stock for Services [Member]
NOTE 3. CRITICAL ACCOUNTING POLICIES (Details) [Line Items]
Share-based Compensation	$ 39,500	$ 50,833

NOTE 4. ACCOUNTS RECEIVABLE (De

NOTE 4. ACCOUNTS RECEIVABLE (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Receivables [Abstract]
Account Receivable, Discount Rate	48.00%	52.00%
Account Receivable, Percentage of Gross Revenue	52.00%	48.00%
Accounts Receivable, Additional Narrative Disclosure	Historical experience, through 2015, demonstrated that the collection period for individual cases may extend for two years or more.
Accounts Receivable, Litigation Settlement, Percent	30.00%	25.00%

NOTE 5. DUE TO RELATED PARTIES

NOTE 5. DUE TO RELATED PARTIES (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Related Party Transactions [Abstract]
Related Parties Amount in Cost of Sales	$ 170,238	$ 125,778
Due to Related Parties, Current	$ 57,336		$ 29,400

NOTE 6. STOCKHOLDERS' EQUITY (D

NOTE 6. STOCKHOLDERS' EQUITY (Details) - Common Stock for Services [Member] - USD ($)	1 Months Ended	3 Months Ended
	Feb. 29, 2016	Mar. 31, 2016
NOTE 6. STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services	25,000
Shares Issued, Price Per Share	$ 0.38
Stock Issued During Period, Value, Issued for Services	$ 9,500
Director [Member]
NOTE 6. STOCKHOLDERS' EQUITY (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services		100,000
Shares Issued, Price Per Share		$ 0.30
Stock Issued During Period, Value, Issued for Services		$ 30,000

NOTE 7. NOTES PAYABLE (Details)

NOTE 7. NOTES PAYABLE (Details) - USD ($)	Sep. 03, 2014	Aug. 20, 2014	Aug. 29, 2012	Jun. 27, 2012	Mar. 31, 2015	Dec. 31, 2014	Jun. 30, 2013	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
NOTE 7. NOTES PAYABLE (Details) [Line Items]
Long-term Line of Credit								$ 1,125,000		$ 1,145,000
Convertible Debt [Member]
NOTE 7. NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Face Amount				$ 500,000
Debt Instrument, Interest Rate, Stated Percentage				12.00%
Debt Instrument, Maturity Date				Mar. 27, 2015
Repayments of Convertible Debt					$ 300,000	$ 200,000
Interest Expense, Debt								0	$ 8,600
Notes Payable, Other Payables [Member]
NOTE 7. NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Face Amount							$ 50,000
Debt Instrument, Maturity Date							Mar. 9, 2017
Interest Expense, Debt								1,250
Class of Warrant or Rights, Granted (in Shares)							50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)							$ 0.45
Line of Credit [Member]
NOTE 7. NOTES PAYABLE (Details) [Line Items]
Interest Expense, Debt								$ 6,680	2,714
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000,000
Line of Credit Facility, Interest Rate at Period End								2.43%
Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
NOTE 7. NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Description of Variable Rate Basis	30 day London Interbank Offered Rate (“LIBOR”)
Debt Instrument, Basis Spread on Variable Rate	2.00%
Director [Member] | Notes Payable, Other Payables [Member]
NOTE 7. NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Face Amount			$ 1,000,000
Debt Instrument, Interest Rate, Stated Percentage		6.00%	12.00%
Debt Instrument, Maturity Date		Aug. 29, 2016
Interest Expense, Debt								$ 7,500	$ 7,500
Debt Instrument, Term		1 year	3 years
Debt Instrument, Collateral Amount			$ 3,000,000
Debt Instrument, Payment Terms			On the maturity date, one balloon payment of the entire outstanding principal amount plus any accrued and unpaid interest is due.
Repayments of Debt		$ 500,000
Notes Payable								$ 500,000